These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36245844)

  • 1. Construction of Prognostic Risk Model for Small Cell Lung Cancer Based on Immune-Related Genes.
    Deng F; Tao F; Xu Z; Zhou J; Gong X; Zhang R
    Comput Math Methods Med; 2022; 2022():7116080. PubMed ID: 36245844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The identification of a two-gene prognostic model based on cisplatin resistance-related ceRNA network in small cell lung cancer.
    Zhang Y; Zhu Q; Qi J; Fu M; Xu A; Wang W; Wang H; Nie J; Hong B
    BMC Med Genomics; 2023 May; 16(1):103. PubMed ID: 37189142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Six Novel Prognostic Gene Signatures as Potential Biomarkers in Small Cell Lung Cancer.
    Feng S; Zhang X; Gu X; Zhou M; Chen Y; Wang C
    Comb Chem High Throughput Screen; 2023; 26(5):938-949. PubMed ID: 35490316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of a prognostic model for lung squamous cell carcinoma based on immune-related genes.
    Pu J; Teng Z; Yang W; Zhu P; Zhang T; Zhang D; Wang B; Hu Z; Song Q
    Carcinogenesis; 2023 May; 44(2):143-152. PubMed ID: 36455238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Immune Infiltration and Prognostic Biomarkers in Small Cell Lung Cancer Based on Bioinformatic Methods from 3 Studies.
    Cao J; Yu C
    Comb Chem High Throughput Screen; 2023; 26(3):507-516. PubMed ID: 35400336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma.
    Yue C; Ma H; Zhou Y
    PeerJ; 2019; 7():e8128. PubMed ID: 31803536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and validation of a prognostic model of angiogenesis-related genes in multiple myeloma.
    Hu R; Chen F; Yu X; Li Z; Li Y; Feng S; Liu J; Li H; Shen C; Gu X; Lu Z
    BMC Cancer; 2024 Oct; 24(1):1269. PubMed ID: 39394121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.
    Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S
    BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y
    Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904
    [No Abstract]   [Full Text] [Related]  

  • 11. Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma.
    Li Y; Shen R; Wang A; Zhao J; Zhou J; Zhang W; Zhang R; Zhu J; Liu Z; Huang JA
    Front Cell Dev Biol; 2021; 9():648806. PubMed ID: 33869203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
    Xu HH; Wang HL; Xing TJ; Wang XQ
    Front Immunol; 2022; 13():851622. PubMed ID: 35924232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of prognostic biomarkers of breast cancer based on the immune-related gene module.
    Wang R; Zeng H; Xiao X; Zheng J; Ke N; Xie W; Lin Q; Zhang H
    Autoimmunity; 2023 Dec; 56(1):2244695. PubMed ID: 37584152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Risk-Assessing Signature Based on Hypoxia- and Immune-Related Genes for Prognosis of Lung Adenocarcinoma Patients.
    Wang Y; Feng J; Liu Y; Han T
    Comput Math Methods Med; 2022; 2022():7165851. PubMed ID: 36213576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Key Biomarkers and Pathways in Small-Cell Lung Cancer Using Biological Analysis.
    Liu H; Li T; Ye X; Lyu J
    Biomed Res Int; 2021; 2021():5953386. PubMed ID: 34712733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and evaluation of a prognostic risk model of tumor metastasis-related genes in patients with non-small cell lung cancer.
    Ding H; Shi L; Chen Z; Lu Y; Tian Z; Xiao H; Deng X; Chen P; Zhang Y
    BMC Med Genomics; 2022 Sep; 15(1):187. PubMed ID: 36056349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a pyroptosis-related lncRNA risk model for predicting prognosis and immune response in colon adenocarcinoma.
    Tan Y; Lu L; Liang X; Chen Y
    World J Surg Oncol; 2022 Apr; 20(1):118. PubMed ID: 35413978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction and Validation of a Prognostic Model Based on mRNAsi-Related Genes in Breast Cancer.
    Zhao X; Lin J
    Comput Math Methods Med; 2022; 2022():6532591. PubMed ID: 36267313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatics analysis of mRNA and miRNA microarray to identify the key miRNA‑gene pairs in small‑cell lung cancer.
    Mao Y; Xue P; Li L; Xu P; Cai Y; Chu X; Jiang P; Zhu S
    Mol Med Rep; 2019 Sep; 20(3):2199-2208. PubMed ID: 31257520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.